Cargando…

VAC chemotherapy with valproic acid for refractory/relapsing small cell lung cancer: a phase II study

Salvage chemotherapy (CT) for relapsing or refractory small cell lung cancer (SCLC) remains disappointing. In vitro experiments showed that valproic acid increases apoptosis of SCLC cell lines exposed to doxorubicin, vindesine and bis(2-chloroethyl)amine. The primary objective of this phase II study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berghmans, Thierry, Lafitte, Jean-Jacques, Scherpereel, Arnaud, Ameye, Lieveke, Paesmans, Marianne, Meert, Anne-Pascale, Colinet, Benoit, Tulippe, Christian, Willems, Luc, Leclercq, Nathalie, Sculier, Jean-Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005117/ https://www.ncbi.nlm.nih.gov/pubmed/27730152 http://dx.doi.org/10.1183/23120541.00029-2015

Ejemplares similares

Prospective Validation Obtained in a Similar Group of Patients and with Similar High Throughput Biological Tests Failed to Confirm Signatures for Prediction of Response to Chemotherapy and Survival in Advanced NSCLC: A Prospective Study from the European Lung Cancer Working Party
por: Berghmans, Thierry, et al.
Publicado: (2015)

Are Intensive Cares Worthwhile for Breast Cancer Patients: The Experience of an Oncological ICU
por: Destrebecq, Virginie, et al.
Publicado: (2016)

A Phase III Randomized Study Comparing a Chemotherapy with Cisplatin and Etoposide to a Etoposide Regimen without Cisplatin for Patients with Extensive Small-Cell Lung Cancer
por: Berghmans, Thierry, et al.
Publicado: (2017)

Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis
por: Meert, Anne-Pascale, et al.
Publicado: (2001)

Advances in target therapy in lung cancer
por: Sculier, Jean-Paul, et al.
Publicado: (2015)

Updates in oncology
por: Sculier, Jean-Paul, et al.
Publicado: (2014)

Continuous Renal Replacement Therapy for Acute Renal Failure in Patients with Cancer: A Well-Tolerated Adjunct Treatment
por: Fischler, Rebecca, et al.
Publicado: (2016)

Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis
por: Martin, B, et al.
Publicado: (2004)

Second-line paclitaxel in non-small cell lung cancer initially treated with cisplatin: a study by the European Lung Cancer Working Party
por: Berghmans, T, et al.
Publicado: (2007)

The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis
por: Meert, A-P, et al.
Publicado: (2002)

The role of HER-2/neu expression on the survival of patients with lung cancer: a systematic review of the literature
por: Meert, A-P, et al.
Publicado: (2003)

Has Cox-2 a prognostic role in non-small-cell lung cancer? A systematic review of the literature with meta-analysis of the survival results
por: Mascaux, C, et al.
Publicado: (2006)

Invasive mechanical ventilation in cancer patients: prior non-invasive ventilation is a poor prognostic factor
por: Meert, A, et al.
Publicado: (2010)

The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis
por: Mascaux, C, et al.
Publicado: (2005)

The role of mitomycin in the treatment of non-small cell lung cancer: a systematic review with meta-analysis of the literature
por: Sculier, J P, et al.
Publicado: (2001)

PARIS score for evaluation of probability of SARS-CoV-2 infection in cancer patients
por: Gueuning, Candice, et al.
Publicado: (2022)

Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis
por: Martin, B, et al.
Publicado: (2003)

Efficacy and Toxicity of Immune -Checkpoint Inhibitors in Patients With Preexisting Autoimmune Disorders
por: Coureau, Michelle, et al.
Publicado: (2020)

Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer
por: Sculier, J-P, et al.
Publicado: (2000)

Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials
por: Charette, Nicolas, et al.
Publicado: (2019)

A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics
por: Sculier, J P, et al.
Publicado: (2001)

Fatal interstitial lung disease associated with oral erlotinib therapy for lung cancer
por: Makris, Demosthenes, et al.
Publicado: (2007)

Critically ill cancer patient’s resuscitation: a Belgian/French societies’ consensus conference
por: Meert, Anne-Pascale, et al.
Publicado: (2021)

Valproic acid improves second-line regimen of small cell lung carcinoma in preclinical models
por: Hubaux, Roland, et al.
Publicado: (2015)

FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer
por: Gombos, Andrea, et al.
Publicado: (2021)

Author Correction: FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer
por: Gombos, Andrea, et al.
Publicado: (2022)

The INTER-ACT E-Health Supported Lifestyle Intervention Improves Postpartum Food Intake and Eating Behavior, but Not Physical Activity and Sedentary Behavior—A Randomized Controlled Trial
por: Bijlholt, Margriet, et al.
Publicado: (2021)

Evolution of Postpartum Weight and Body Composition after Excessive Gestational Weight Gain: The Role of Lifestyle Behaviors—Data from the INTER-ACT Control Group
por: Bijlholt, Margriet, et al.
Publicado: (2021)

Recommendations of the VAC2VAC workshop on the design of multi-centre validation studies
por: Halder, Marlies, et al.
Publicado: (2018)

Circulating tumor DNA in early response assessment and monitoring of advanced colorectal cancer treated with a multi-kinase inhibitor
por: Vandeputte, Caroline, et al.
Publicado: (2018)

INTER-ACT: prevention of pregnancy complications through an e-health driven interpregnancy lifestyle intervention – study protocol of a multicentre randomised controlled trial
por: Bogaerts, Annick, et al.
Publicado: (2017)

Phase Angle and Bio-Impedance Values during the First Year after Delivery in Women with Previous Excessive Gestational Weight Gain: Innovative Data from the Belgian INTER-ACT Study
por: Bijlholt, Margriet, et al.
Publicado: (2021)

The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients
por: Lambertini, Matteo, et al.
Publicado: (2016)

The Prognostic Significance of Metabolic Response Heterogeneity in Metastatic Colorectal Cancer
por: Hendlisz, Alain, et al.
Publicado: (2015)

Feasibility Study of EndoTAG-1, a Tumor Endothelial Targeting Agent, in Combination with Paclitaxel followed by FEC as Induction Therapy in HER2-Negative Breast Cancer
por: Ignatiadis, Michail, et al.
Publicado: (2016)

Radiopharmaceuticals for Relapsed or Refractory Leukemias
por: Kunos, Charles A., et al.
Publicado: (2019)

Relapsed/Refractory Hodgkin Lymphoma
por: Sheikh, Semira, et al.
Publicado: (2018)

Sex differences in fetal growth and immediate birth outcomes in a low-risk Caucasian population
por: Galjaard, Sander, et al.
Publicado: (2019)

Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocol
por: Hendlisz, Alain, et al.
Publicado: (2015)

Tolerability to romidepsin in patients with relapsed/refractory T-cell lymphoma
por: Foss, Francine, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_j46a9vc7q482cmfo63dmpdg5gu